Tandem Diabetes Care (TNDM) Equity Income (2024 - 2026)

Tandem Diabetes Care (TNDM) has 3 years of Equity Income data on file, last reported at -$3.9 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Income fell 11.43% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$14.5 million (down 161.62% YoY), and the FY2025 full-year result was -$14.2 million, down 591.38% from the prior year.
• Equity Income for Q1 2026 stood at -$3.9 million, up from -$4.6 million in the prior quarter.
• Across five years, Equity Income topped out at -$2.1 million in Q4 2024 and bottomed at -$4.6 million in Q4 2025.
• The 3-year median for Equity Income is -$3.4 million (2025), against an average of -$3.3 million.
• The widest annual swing landed in 2025, when Equity Income plunged 121.77%; it then fell 11.43% in 2026.
• A 3-year view of Equity Income shows it stood at -$2.1 million in 2024, then slumped by 121.77% to -$4.6 million in 2025, then rose by 14.34% to -$3.9 million in 2026.
• The last three Equity Income figures came in at -$3.9 million (Q1 2026), -$4.6 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.

Peer Comparison